Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
暂无分享,去创建一个
W. V. van IJcken | H. Hoogsteden | J. Foekens | F. Grosveld | P. Riegman | J. Aerts | J. Hou | B. den Hamer | M. D. den Bakker | C. H. van der Leest | P. J. van der Spek | S. Philipsen | W. V. van Ijcken | Bianca den Hamer
[1] Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. , 1997, American journal of respiratory and critical care medicine.
[2] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[3] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Travis,et al. The new World Health Organization classification of lung tumours , 2001, European Respiratory Journal.
[7] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[8] R. Strausberg,et al. A preliminary transcriptome map of non-small cell lung cancer. , 2002, Cancer research.
[9] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. You,et al. Differentially expressed genes associated with mouse lung tumor progression , 2002, Oncogene.
[11] Chan Zeng,et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Yusuke Nakamura,et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs , 2003, Oncogene.
[13] M. Radmacher,et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.
[14] R. Tibshirani,et al. Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.
[15] Petri Auvinen,et al. Are data from different gene expression microarray platforms comparable? , 2004, Genomics.
[16] J. Yokota,et al. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo , 2004, Oncogene.
[17] Carl Virtanen,et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles , 2004, The Lancet.
[18] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[19] S. Mukherjee,et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.
[20] D. Haber,et al. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Ferlay,et al. Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] Jeremy J. W. Chen,et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.
[23] Marcin Skrzypski,et al. Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung , 2008, Clinical Cancer Research.
[24] Dongyun Yang,et al. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. , 2008, Cancer research.
[25] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[26] Johan Vansteenkiste,et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Nam Huh,et al. Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression , 2008, Clinical Cancer Research.
[28] Yong Qian,et al. Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.
[29] Marcin Skrzypski,et al. An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer , 2009, Clinical Cancer Research.
[30] M. Raica,et al. Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[31] Igor Jurisica,et al. Prognostic gene signatures for non-small-cell lung cancer , 2009, Proceedings of the National Academy of Sciences.
[32] D.,et al. Regression Models and Life-Tables , 2022 .